StemCultures Introduces FGF2 DISC™ Devices for Precise Control of Fibroblast Growth Factor 2 Concentration during Cell Culture

~ The DISC™ device releases FGF2 at a controlled rate, minimizing variations in concentration and providing stable FGF2 levels with improved control for higher quality cultures ~ Controlled levels of FGF2 reduce spontaneous differentiation, enhance pluripotency and improve the differentiation efficiency of stem cell cultures. RENSSELAER, New York – StemCultures, a life sciences company developing [...]

Lunaphore appoints Janis Taube, M.D., M.Sc., to Scientific Advisory Board

LAUSANNE, Switzerland – Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, today announced the appointment of Janis M. Taube, M.D., M.Sc., a leading pathologist and expert on immunotherapy research, to its Scientific Advisory Board. As an advisor, Dr. Taube will provide strategic advisory support to Lunaphore’s scientific activities and product [...]

Bruker Acquires Prolab Instruments to Augment Multiomics Solutions

Prolab precision pumps, autosamplers and nano-flow to cap-LC UHPLC systems to further enhance performance and robustness of timsTOF 4D proteomics and metabolomics solutions Unique Zirconium™ nano-LC to cap-LC pump technology for 4 nL/min to 10 μL/min flow rates with split-less UHPLC operation for optimized proteomics results Innovative, proprietary Zirconium Cube™ autosampler with mobile injection unit technology for precise, ultra-low volume injections in [...]

Dolomite Bio announce launch of cost-effective Bioinformatics service with brand new RNAdia kit for single cell research

Following the recent launch of Dolomite Bio’s RNAdia kit for single cell research. Dolomite Bio is now launching a Bioinformatics Service, which can be purchased alongside the kit as simply as if you were buying reagents. With upfront costs, allowing for easy forecasting, cost-effective and hassle-free single cell RNA-Sequencing. Data analysis is an essential part [...]

QIAGEN supports young biotechnology and pharma companies by announcing winners of first-ever annual Biotech Grants

Prizes of QIAGEN products and equipment go to three companies in the US and one in the EU QIAGEN lends companies unique support in areas from research to commercialization Runners-up in large, high-quality field get to join QIAGEN’s Biotech Accelerator Program Germantown, Maryland, and Hilden, Germany – QIAGEN today announced the winners of its new Biotech [...]

SCIENION Partners with Institute for Prevention and Occupational Medicine (IPA) to Develop UROfast, a Rapid Bladder Cancer Diagnostics Platform

The breakthrough diagnostics platform uses a multiplexed lateral flow assay that detects 10 bladder cancer biomarkers from a urine sample in either laboratory or point-of-care settings. Today SCIENION, a BICO company and leading developer of miniaturized multiplex diagnostic tests, announced a partnership with the Institute for Prevention and Occupational Medicine of the German Social Accident [...]

CDD VAULT CELEBRATES 3-MILLIONTH USER LOGIN WITH GYREOX THERAPEUTICS

CDD is delighted to be celebrating another achievement. In December 2021, a member of UK based GyreOx Therapeutics made the lucky 3-millionth login to the CDD Vault hosted informatics platform. Romario Ferreira-Pontes recently joined GyreOx in his first role after completing his MChem at The University of Manchester, and has joined the team in using CDD Vault for data [...]

Parse Biosciences Announces Partnership With Research Instruments Group to Offer RNA-Seq Kits in Singapore and Southeast Asia Region

SEATTLE -- Parse Biosciences, a company providing researchers with single-cell sequencing solutions, today announced a partnership with Research Instruments Pte Ltd to provide Parse’s Evercode Whole Transcriptome Kits (WTKs), Cell Fixation Kits and Nuclei Fixation Kits to markets in Singapore and Southeast Asia. Under an agreement between the two parties, Research Instruments has been appointed a distributor [...]

Oncocyte Announces Development and Co-Marketing Agreement with Thermo Fisher Scientific to Expand Access to Precision Oncology

Collaboration extends global reach for Thermo Fisher’s rapid next-generation sequencing technology Conference call to be held today at 4:30 pm ET/1:30 pm PT IRVINE, Calif. -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company with the mission to improve patient outcomes by providing clear insights that inform critical decisions in the diagnosis, treatment, and monitoring [...]

Codex DNA Showcases Potential of Groundbreaking SOLA Enzymatic DNA Synthesis Approach to …

Proprietary short oligo ligation assembly (SOLA) technology used to enzymatically synthesize DNA fragments for the construction of full-length H1 and N1 genes from influenza A virusInitial performance results show potentially significant quality, time, and cost advantages compared to traditional chemical synthesis and alternative enzymatic DNA synthesis approaches SAN DIEGO, Jan. 18, 2022 (GLOBE NEWSWIRE) -- [...]

Access IBO on Knowledge Center